Citigroup’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $95.7K | Sell |
|
|||||
|
2025
Q1 | $124K | Sell |
|
|||||
|
2024
Q4 | $124K | Buy |
|
|||||
|
2024
Q3 | $68.6K | Buy |
|
|||||
|
2024
Q2 | $22.4K | Sell |
|
|||||
|
2024
Q1 | $999K | Buy |
|
|||||
|
2023
Q4 | $361K | Buy |
|
|||||
|
2023
Q3 | $29K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $0 | Sell |
|
|||||
|
2022
Q1 | $2K | Sell |
|
|||||
|
2021
Q4 | $19K | Buy |
|
|||||
|
2021
Q3 | $13K | Buy |
|
|||||
|
2021
Q2 | $8K | Buy |
|